Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden

NCT01356914 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: BMS-914392
DRUG: BMS-914392
DRUG: BMS-914392
DRUG: Placebo

Sponsor

Bristol-Myers Squibb